Michael R. Mross

802 citations
11 papers · 617 · 1 hit paper · h-index 8

Impact in

  • Genetics top 5%
    • Inflammatory Bowel Disease
  • Oncology top 10%
    • Colorectal Cancer Screening and Detection
    • Colorectal Cancer Surgical Treatments

Papers in

    • Inflammatory Bowel Disease 6
    • Colorectal Cancer Screening and Detection 3

Michael R. Mross

11 papers receiving 593 citations

Michael R. Mross's Hit Papers

Risankizumab for Ulcerative Colitis 2024 · 80 citations
800+1Years since publication255075

Peers

Michael R. Mross
Comparison fields: 5 of 25
  • Genetics 327
  • Oncology 202
  • Family Practice 12
  • Hematology 11
  • Neurology 2
Replace Antonio Soriano with:
Antonio Soriano Spain
Nicholas J. Combates United States
Caroline E. Porter United States
Elisabetta Razzaboni Italy
Zlata Novalić Netherlands
Xue-Liang Jiang China
A. Parikh United States
Michiel E. de Jong Netherlands
Jana de Sostoa Spain
Martin Laclav Czechia
Michael R. Mross relative to Antonio Soriano Spain Antonio Soriano's profile →
Citations per field
00.5×2×4×6×8.8×
Antonio Soriano · 1×
Citations per year

Countries citing papers authored by Michael R. Mross

Since Specialization
Citations

This map shows the geographic impact of Michael R. Mross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Mross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Mross more than expected).

Fields of papers citing papers by Michael R. Mross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Mross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Mross. The network helps show where Michael R. Mross may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael R. Mross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael R. Mross Line = papers co-authored together Michael R. Mross links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 2012187
2 2012142
3 2009119
4
Risankizumab for Ulcerative Colitis
Hit paper breakdown →
202480
5 202032
6 201330
7 201613
8 20178
9 20113
10
Pentasa (mesalazine) once or twice daily for the management of maintenance of remission of ulcerative colitis: Demographic and baseline data of a 12 month single blind randomised controlled trial
20072
11 20241

About Michael R. Mross

Michael R. Mross is a scholar working on Genetics, Oncology, Health, Hematology and Nuclear Energy and Engineering, having authored 11 papers that have together received 617 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Colorectal Cancer Screening and Detection (3 papers), Iron Metabolism and Disorders (1 paper) and Vaccine Coverage and Hesitancy (1 paper). The work is most often cited by research in Genetics (327 citations), Oncology (202 citations), Family Practice (12 citations), Hematology (11 citations) and Neurology (2 citations). Michael R. Mross has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Severine A.R.A. Vermeire, Alireza Aminalai, Ulrich Gauger, Rolf Drossel, Jens Aschenbeck, Bertram J. Wiedenmann, L Altenhofen, David A. Lieberman, Andreas Adler and Gabriela Stange. Their work appears in journals such as Gut, Gastroenterology, BMC Gastroenterology, Inflammatory Bowel Diseases and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact